SciSparc subsidiary NeuroThera Labs validates quantum sampling workflow for clinical trials analytics platform - SPRC News | RalliesSciSparc subsidiary NeuroThera Labs validates quantum sampling workflow for clinical trials analytics platform
S
SPRC• NeuroThera Labs validates quantum sampling workflow
- SciSparc unit NeuroThera Labs completed internal validation of a proprietary quantum sampling workflow for clinical trials data analytics.
- The workflow was developed on a hybrid quantum-classical computing platform operated by an unnamed S&P 500 company.
- NeuroThera said the approach converts continuous datasets into quantum-operable representations to support Quantum Markov Chain Monte Carlo methods.
- Platform development runs through CliniQuantum, a quantum analytics initiative in which NeuroThera holds 54.01%.
